Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

Por um escritor misterioso
Last updated 28 julho 2024
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – Page 2 – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
00409-4264-01 Pfizer Hospital US
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Almaject Inc 47781058629 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Press Releases – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
AbbVie Inc 00074334603 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Certa Dose Inc 71754000105 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Labetalol LABETALOL, Labetalol HCL Inj; Vial; 5mg/mL. 20 mL $28.75
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Hospira 00409379501 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Hospira 00409475503 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – The Ritedose Corporation

© 2014-2024 hellastax.gr. All rights reserved.